Back to search

Article

Monoclonal antibodies targeting surface exposed epitopes of <i>Candida albicans</i> cell wall proteins confer <i>in vivo</i> protection in an infection model

2021-09-29

Abstract excerpt

MAb based immunotherapies targeting systemic and deep-seated fungal infections are still in their early stages of development with currently no licensed antifungal mAbs available for patients at risk. The cell wall glycoproteins of Candida albicans are of particular interest as potential targets for therapeutic antibody generation due to their extracellular location and key involvement in fungal pathogenesis. Her...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d93dc964-85a2-547d-b0a1-a34fedf053d5
DOI
10.1101/2021.09.29.462385
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Monoclonal antibodies targeting surface exposed epitopes of <i>Candida albicans</i> cell wall proteins confer <i>in vivo</i> protection in an infection modelDOI 10.1101/2021.09.29.462385
Select a neighboring publication to make it the new centre.